Financing ·
GSK plc announced the admission of 70,759 ordinary shares to trading on the London Stock Exchange Main Market between…
GLAXFGSK plc
GSK plc announced the admission of 70,759 ordinary shares to trading on the London Stock Exchange Main Market between 29 May 2026 and 24 July 2026. These shares were issued under the existing GlaxoSmithKline plc Share Save Plan 2022, bringing the total number of admitted securities to 4,316,292,310. GSK is a global biopharma company focused on disease prevention and treatment through science and technology.